STF-logo-1

We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Kelly Curtin at Stifel

Kelly Curtin

Managing Director

Healthcare

BioPharma

London

kelly.curtin@stifel.com | 44-20-3465-1202 | v-Card

Kelly Curtin is a Managing Director in Stifel’s Global Healthcare Group with over 20 years of experience in investment banking, primarily in the healthcare industry. Her experience includes strategic transactions across a wide spectrum of the life sciences, including biotechnology, pharma, specialty pharma, generics, healthcare services, and medical devices. Kelly has led M&A transactions for public and private companies, licensing transactions and divestments as well as executed a range of equity and debt financings. Kelly became part of Stifel in 2023 through the Torreya acquisition.

Before joining Torreya in 2014, Kelly was a Director in Credit Suisse’s Mergers & Acquisitions group in both Chicago and London.

Kelly holds a B.A. in Law, Jurisprudence and Social Thought from Amherst College.